Facebook
Twitter
Telegram
Fehler meldenMirati Therapeutics Finanzdaten 2011-2024 | MRTX
Jahresabschluß Mirati Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Marktkapitalisierung |
2.56 B | 7.61 B | 9.88 B | 3.26 B | 2.02 B | 645 M | 99.9 M | 364 M | 280 M | 231 M | - | - |
Anteile |
56.2 M | 51.9 M | 45 M | 37.5 M | 30.9 M | 25.3 M | 19.8 M | 16.9 M | 13.5 M | 11.1 M | - | - |
Kurshistorie |
45.6 | 147 | 220 | 129 | 42.4 | 18.2 | 4.75 | 31.6 | 18.5 | 16.6 | - | - |
Nettogewinn |
-741 M | -582 M | -358 M | -213 M | -98.4 M | -70.5 M | -83.1 M | -64.5 M | -43.7 M | -52.9 M | -20.4 M | -9.53 M |
Umsatz |
12.4 M | 72.1 M | 13.4 M | 3.34 M | 12.9 M | - | - | - | - | - | 2.01 K | 3.03 M |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | - | - | 3.03 M |
Betriebsergebnis |
-760 M | -573 M | -369 M | -222 M | -103 M | -71.5 M | -83.8 M | -64.7 M | -39.1 M | -32 M | -20.5 M | - |
Zinsaufwendungen |
19.2 M | -5.3 M | 11.4 M | 8.85 M | 4.21 M | 1.1 M | 661 K | 170 K | -77 K | -1.08 M | 251 K | - |
EBITDA |
-757 M | -571 M | -369 M | -222 M | -102 M | -71.4 M | -83.6 M | -64.5 M | -38.6 M | -30.8 M | -20.4 M | -9.6 M |
Betriebsaufwand |
772 M | 645 M | 383 M | 225 M | 116 M | 71.5 M | 83.8 M | 64.7 M | 38.8 M | 30.9 M | - | 12.8 M |
Allgemeine und Verwaltungsausgaben |
240 M | 137 M | 83.4 M | 42.6 M | 21.7 M | 13.4 M | 15.3 M | 15.8 M | 12.7 M | 11.1 M | 5.41 M | - |
Alle Zahlen in USD-Währung
Gewinn / Verlust Vierteljährlich Mirati Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteile |
65 M | 58.2 M | 58 M | 57.9 M | 56.2 M | 55.6 M | 55.5 M | 55.4 M | 51.7 M | 51.5 M | 50.8 M | 50.4 M | 44.6 M | 43.8 M | 42.9 M | 39.5 M | 39.2 M | 36.2 M | 35 M | 32.5 M | 32.4 M | 29.8 M | 28.8 M | 28.6 M | 25 M | 25 M | 24.4 M | 19.9 M | 19.9 M | 19.9 M | 19.4 M | 19.3 M | 16.8 M | 16.2 M | 15.5 M | 13.6 M | 13.5 M | 13.5 M | 13.5 M | 13.4 M | 9.96 M | 9.96 M | 9.96 M | 9.96 M | 6.36 M | 6.36 M | - | - | - | - | - |
Nettogewinn |
-162 M | -177 M | -185 M | - | -174 M | -176 M | -188 M | -200 M | -80.1 M | -166 M | -136 M | -101 M | -87.3 M | -82.9 M | -86.7 M | -72.4 M | -54.3 M | -45.7 M | -40.9 M | -28.3 M | -27.6 M | -27.9 M | -14.7 M | -17.9 M | -16.4 M | -18.3 M | -17.8 M | -19.7 M | -19.4 M | -22.1 M | -21.9 M | -18.4 M | -18.7 M | -15.4 M | -11.9 M | -10.4 M | -8.62 M | -11 M | -13.7 M | - | -29.4 M | -8.01 M | -4.22 M | - | -5.95 M | -4.68 M | - | - | - | - | - |
Umsatz |
16.4 M | 13.7 M | 7.17 M | - | 5.43 M | 5.36 M | 709 K | 299 K | 71.8 M | - | - | 1.71 M | 11.4 M | - | 267 K | 526 K | 988 K | 577 K | 1.24 M | 3.46 M | - | - | 9.47 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-172 M | -187 M | -194 M | - | -186 M | -177 M | -184 M | -197 M | -79.5 M | -164 M | -132 M | -106 M | -88.7 M | -84.9 M | -89.5 M | -74.6 M | -57.1 M | -47.6 M | -42.8 M | -29.7 M | -28.9 M | -28.7 M | -15.3 M | -18.2 M | -16.6 M | -18.6 M | -18.1 M | -19.9 M | -19.6 M | -22.2 M | -22.1 M | -18.5 M | -18.7 M | -15.5 M | -12 M | -10.4 M | -10.5 M | -10.1 M | -7.98 M | -7.89 M | -9.21 M | -6.9 M | -8.01 M | - | -5.97 M | -4.73 M | - | - | - | - | - |
Zinsaufwendungen |
10.2 M | 10.4 M | 9.24 M | - | 13.1 M | 760 K | -4.17 M | - | 2.74 M | -2.24 M | -3.26 M | - | 1.34 M | 2 M | 2.83 M | - | 2.79 M | 1.95 M | 1.85 M | - | 1.37 M | 801 K | 637 K | - | 251 K | 277 K | 244 K | - | 160 K | 166 K | 204 K | - | -17 K | 70 K | 46 K | - | 24 K | 73 K | -202 K | - | 462 K | -694 K | -570 K | - | 34 K | 70 K | - | - | - | - | - |
EBITDA |
-172 M | -187 M | -193 M | - | -184 M | -177 M | -184 M | -197 M | -78.3 M | -164 M | -132 M | -106 M | -88.5 M | -84.8 M | -89.4 M | -74.6 M | -56.9 M | -47.5 M | -42.7 M | -29.7 M | -28.9 M | -28.6 M | -15.3 M | -18.2 M | -16.6 M | -18.5 M | -18 M | -19.9 M | -19.4 M | -22.1 M | -22.1 M | -18.5 M | -18.7 M | -15.5 M | -11.9 M | -10.4 M | -10.5 M | -10.1 M | -7.9 M | -7.89 M | -9.17 M | -6.86 M | -7.98 M | - | -5.87 M | -4.67 M | - | - | - | - | - |
Betriebsaufwand |
188 M | 201 M | 201 M | - | 192 M | 183 M | 185 M | - | 151 M | 164 M | 132 M | - | 100 M | 84.9 M | 89.8 M | - | 58 M | 48.2 M | 44 M | - | 28.9 M | 28.7 M | 24.8 M | - | 16.6 M | 18.6 M | 18.1 M | - | 19.6 M | 22.2 M | 22.1 M | - | 18.7 M | 15.5 M | 12 M | - | 10.5 M | 10.1 M | 7.98 M | - | 9.21 M | 6.89 M | 8 M | - | 5.97 M | 4.73 M | - | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
72 M | 75.5 M | 73.5 M | - | 60.8 M | 54.2 M | 54 M | - | 35.2 M | 29.6 M | 28.4 M | - | 20.2 M | 19.8 M | 18 M | - | 10.7 M | 9.89 M | 9.76 M | - | 5.31 M | 4.84 M | 5.15 M | - | 3.12 M | 3.65 M | 3.69 M | - | 3.48 M | 3.79 M | 4.13 M | - | 4.16 M | 4.24 M | 3.78 M | - | 3.66 M | 2.99 M | 2.68 M | - | 3.72 M | 2.38 M | 2.52 M | - | 1.72 M | 1.08 M | - | - | - | - | - |
Alle Zahlen in USD-Währung